ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 5176

$3.25M Total Retail Price of All Prescriptions

Rank: 10 out of 5176

1,435 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,435 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 27,275 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 2,080 1,892 10 1 65
SIMVASTATIN 1,400 1,262 2 1
AMLODIPINE BESYLATE 1,381 1,307 3 2
NEXIUM 1,207 1,074 4 16
ALENDRONATE SODIUM 968 923 5 18
LIDODERM 867 779 6 59
LOVAZA 811 720 7 43
CRESTOR 721 640 8 15
DIOVAN 688 639 9 19
GLYBURIDE-METFORMIN HCL 612 558 R 10 76
LOSARTAN POTASSIUM 606 541 11 14
OMEPRAZOLE 575 523 12 3
FLUTICASONE PROPIONATE 560 508 13 38
ATORVASTATIN CALCIUM 540 484 14 9
METOPROLOL SUCCINATE 538 512 15 11
JANUVIA 528 506 16 25
CLOBETASOL PROPIONATE 524 487 17 130
DIOVAN HCT 449 430 18 39
ATENOLOL 444 390 19 12
PATANOL 431 392 20 158
METFORMIN HCL 430 379 21 7
TAMSULOSIN HCL 404 390 22 20
AZITHROMYCIN 391 333 23 42
PLAVIX 366 333 24 29
AMMONIUM LACTATE 324 280 25 91
AVODART 323 319 26 107
LEVOTHYROXINE SODIUM 320 274 27 4
LOSARTAN-HYDROCHLOROTHIAZIDE 318 271 28 35
ALLOPURINOL 301 288 29 41
BENICAR 274 267 30 100
LISINOPRIL 261 254 31 5
LIPITOR 260 250 32 51
ZOLPIDEM TARTRATE 238 217 33 17
PROAIR HFA 226 202 34 60
GLIMEPIRIDE 223 214 35 37
ADVAIR DISKUS 207 184 36 32
TRIAMCINOLONE ACETONIDE 207 166 36 125
CLOPIDOGREL 200 181 38 26
ACTONEL 197 185 39 134
GEMFIBROZIL 193 164 40 139
MECLIZINE HCL 191 176 41 81
ISOSORBIDE MONONITRATE ER 188 185 42 44
TRICOR 185 174 43 148
SINGULAIR 179 166 44 62
FUROSEMIDE 178 178 45 8
VOLTAREN 160 144 46 97
MELOXICAM 159 155 47 53
LIDOCAINE 158 146 48 179
METOPROLOL TARTRATE 154 149 49 6
ACTOS 151 137 50 85
CARVEDILOL 150 146 51 24
PROCTOZONE-HC 146 139 52 171
CELEBREX 135 113 53 80
CIPROFLOXACIN HCL 112 100 54 84
SINGLE USE SWAB 112 102 54 108
RANITIDINE HCL 107 89 56 36
MONTELUKAST SODIUM 101 89 57 123
PRANDIN 97 97 58 150
BENICAR HCT 97 89 58 110
SYNTHROID 95 71 60 33
POLYETHYLENE GLYCOL 3350 90 90 61 74
CLOTRIMAZOLE-BETAMETHASONE 88 82 62 94
AMOXICILLIN 88 76 62 163
FAMOTIDINE 84 82 64 58
NASONEX 84 64 64 178
LANTUS SOLOSTAR 81 63 66 70
RANEXA 78 68 67 167
AGGRENOX 77 65 68 235
VENTOLIN HFA 76 66 69 64
BYSTOLIC 75 71 70 96
MOMETASONE FUROATE 74 66 71 251
SPIRIVA 74 68 71 54
GLYBURIDE 72 62 R 73 67
DONEPEZIL HCL 71 71 74 28
ISOSORBIDE DINITRATE 71 61 74 288
COLCRYS 70 70 76 170
PREDNISONE 70 65 76 52
LANSOPRAZOLE 70 57 76 113
ENALAPRIL MALEATE 68 53 79 22
FINASTERIDE 68 63 79 69
CYCLOBENZAPRINE HCL 65 64 R 81 143
RAMIPRIL 64 62 82 50
GLIPIZIDE 64 54 82 63
NAPROXEN 63 56 84 95
PRAVASTATIN SODIUM 63 56 84 23
HYDROCHLOROTHIAZIDE 58 49 86 10
GABAPENTIN 56 40 87 21
DOXAZOSIN MESYLATE 54 45 88 103
VIREAD 53 53 89 250
ALFUZOSIN HCL 53 46 89 462
BARACLUDE 52 52 91 373
CLONIDINE HCL 52 52 91 79
CICLOPIROX 52 52 91 279
MICARDIS 52 33 91 154
VYTORIN 52 52 91 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.